BioMarin Pharmaceutical | Capitaux D'Emprunt



Loan Capital Changement Date
Acadia Pharmaceuticals USD 0 0 2025-03
Agios Pharmaceuticals USD 0 0 2025-03
Alnylam Pharmaceuticals USD 1.03B 956K 2025-06
Amgen USD 53.76B 253M 2025-06
Bayer EUR 31.71B 3.31B 2025-06
Biogen USD 6.28B 1.74B 2025-06
BioMarin Pharmaceutical USD 596.16M 512K 2025-06
Gilead Sciences USD 22.14B 6M 2025-06
Incyte USD 31.76M 883K 2025-06
Insmed USD 560.95M 567.39M 2025-06
Ionis Pharmaceuticals USD 625.49M 625.22M 2025-06
Moderna USD 32M 3M 2025-06
Neurocrine Biosciences USD 0 0 2024-12
PTC Therapeutics USD 2.13B 1.85B 2025-06
Regeneron Pharmaceuticals USD 1.99B 719.7M 2025-06
Roche Holding CHF 32.1B 1.94B 2024-12
Sanofi 11.79B 712M 2024-12
Sarepta Therapeutics USD 1.14B 1.17M 2025-06
Ultragenyx Pharmaceutical USD 782.75M 782.75M 2025-06
United Therapeutics USD 0 0 2025-03
Vertex Pharmaceuticals USD 112.8M 1.2M 2024-12


BioMarin Pharmaceutical Capitaux D'Emprunt - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Aug 2025.